We have reported on the role of the autophagy markers LC3B and p62 in primary resected EAC in a treatment chemo-naïve setting showing that low LC3B and low p62 expression is associated with worse outcome in, chemo-naïve carcinomas. The gene discussed is MAP1LC3B; the disease is carcinoma.